Cerebrospinal fluid biomarker development in amyotrophic lateral sclerosis

Cerebrospinal fluid biomarker development in amyotrophic lateral sclerosis

<p>Amyotrophic lateral sclerosis (ALS), the commonest form of motor neuron disease (MND), is a fatal, typically rapidly-progressive neurodegenerative syndrome without highlyeffective disease-modifying treatment. A diverse range of upstream cellular perturbations converge on a common clinical p...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Thompson, AG
Altri autori:	Turner, M
Natura:	Tesi
Lingua:	English
Pubblicazione:	2018
Soggetti:	Neurosicences Neurology

Documenti analoghi

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
di: Thompson, A, et al.
Pubblicazione: (2018)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.
di: Gray, E, et al.
Pubblicazione: (2015)

Biomarkers in amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2009)

Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis
di: Thompson, AG, et al.
Pubblicazione: (2021)

Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis
di: Dellar, ER, et al.
Pubblicazione: (2023)

Untangling neuroinflammation in amyotrophic lateral sclerosis
di: Thompson, AG, et al.
Pubblicazione: (2019)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
di: Bowser, R, et al.
Pubblicazione: (2011)

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2013)

Motor system biomarkers in amyotrophic lateral sclerosis
di: Edmond, EC, et al.
Pubblicazione: (2019)

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers
di: Vahsen, BF, et al.
Pubblicazione: (2021)

TDP-43 based biomarker development in amyotrophic lateral sclerosis
di: Feneberg, E
Pubblicazione: (2019)

Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis
di: Turner, M
Pubblicazione: (2018)

Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2011)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2015)

Biomarkers of motor network excitability in amyotrophic lateral sclerosis
di: Edmond, E
Pubblicazione: (2022)

A systematic review of biomarkers for disease progression in Parkinson's disease.
di: McGhee, D, et al.
Pubblicazione: (2013)

Amyotrophic lateral sclerosis.
di: Kiernan, M, et al.
Pubblicazione: (2011)

MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?
di: Turner, M
Pubblicazione: (2011)

Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis
di: Joilin, G, et al.
Pubblicazione: (2020)

The reunification of amyotrophic lateral sclerosis
di: Turner, M
Pubblicazione: (2018)

Neuroimaging in amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2012)

The genetics of amyotrophic lateral sclerosis
di: Schymick, J
Pubblicazione: (2009)

Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study
di: Steinacker, P, et al.
Pubblicazione: (2021)

CSF chitinase proteins in amyotrophic lateral sclerosis
di: Thompson, A, et al.
Pubblicazione: (2019)

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
di: Steinacker, P, et al.
Pubblicazione: (2017)

Retromer dysfunction in amyotrophic lateral sclerosis
di: Fraenkel, Ernest
Pubblicazione: (2023)

Controversies and priorities in amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2013)

Genetics of sporadic amyotrophic lateral sclerosis.
di: Schymick, J, et al.
Pubblicazione: (2007)

Neuroimaging endpoints in amyotrophic lateral sclerosis
di: Menke, R, et al.
Pubblicazione: (2016)

Development of novel diagnostics and therapeutics for amyotrophic lateral sclerosis
di: Townsend, Seth A. (Seth Alan)
Pubblicazione: (2009)

Amyotrophic lateral sclerosis: the complex path to precision medicine
di: Talbot, K, et al.
Pubblicazione: (2018)

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
di: Thompson, AG, et al.
Pubblicazione: (2022)

Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis.
di: Hudson, A, et al.
Pubblicazione: (1993)

Defining pre-symptomatic amyotrophic lateral sclerosis
di: Benatar, M, et al.
Pubblicazione: (2019)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
di: Evans, M, et al.
Pubblicazione: (2013)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis
di: Evans, M, et al.
Pubblicazione: (2013)

Defective cholesterol metabolism in amyotrophic lateral sclerosis.
di: Abdel-Khalik, J, et al.
Pubblicazione: (2016)

Quantifying disease progression in amyotrophic lateral sclerosis.
di: Simon, N, et al.
Pubblicazione: (2014)

Myelin imaging in amyotrophic and primary lateral sclerosis.
di: Kolind, S, et al.
Pubblicazione: (2013)

Advances in the application of MRI to amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2010)